Skip to main content

Age and sex differences in soluble ACE2 may give insights for COVID-19

  • The Letter to this article has been published in Critical Care 2020 24:396

To the editor:

mACE2 (membrane-bound angiotensin-converting enzyme 2) is central when developing severe COVID-19 (coronavirus disease 2019), because SARS-CoV-2 (severe acute respiratory syndrome coronavirus-2) attaches to the active surface domain of mACE2 when entering the host cell [1]. ADAM-17 (a disintegrin and metalloproteinase-17), during physiological conditions and in SARS-CoV infection, can cleave mACE2, resulting in shedding and soluble ACE2 (sACE2) [2, 3], a process also associated with ALI (acute lung injury) [1]. High mACE2 and/or high ADAM-17 activity may therefore facilitate SARS CoV-2 infection and severe COVID-19, and sACE2 may capture this risk, reflecting (i) high mACE2, (ii) high ADAM-17 activity, or (iii) both.

Severe COVID-19 is more common in adults than in children and in men than women [4]. This may be related to differences in mACE2 expression and/or age-related alterations in the RAS (renin-angiotensin system), associated with increased angiotensin II/ADAM-17 activity and increased mACE2 shedding [1, 2, 5]. The aim of this study was to evaluate sACE2 levels during growth and compare results by sex and age.

We analyzed sACE2 in serum collected at mean ages (SD) 9.9 (0.6), 11.7 (0.6), 14.8 (0.8), 18.8 (0.3), and 23.5 (0.7) years in individuals in the pediatric osteoporosis prevention (POP) study, a prospective study that investigates the effects of physical activity on musculoskeletal development through growth (Ethics Committee of Lund University, Sweden LU 2015/118) [6]. sACE2 was analyzed by Olink® Inflammation Cardiovascular II panel. Data is presented as Normalized Protein eXpression (NPX) values, which is an arbitrary unit on a log2 scale (Olink Proteomics AB, Uppsala, Sweden; Seven outlier observations of sACE2 that deviated more than 3 SD from the gender-specific mean were removed from the analyses. Characteristics of subjects included in the analyses of the present study are presented in Table 1. Differences in sACE2 between male and female subjects were calculated using analysis of covariance, adjusted for age. The level of significance was set at p < 0.05, and analyses were performed using the SPSS statistical package (v26; SPSS Inc., Chicago, Ill).

Table 1 Subject background data and sACE2 levels in relation to age and sex

There was similar and low sACE2 in both sexes up to age 12. sACE2 increased more in boys with growth, so men from age 15 had higher sACE2 than women (Fig. 1). Thus, sACE2 is low in children and increases more in boys than girls, resulting in sex differences in adolescence/young adulthood.

Fig. 1

Sex-specific levels of sACE2 in relation to age. Data is presented as Normalized Protein eXpression (NPX) values, which is an arbitrary unit on a log2 scale, as mean with error bars representing 95% confidence intervals

SARS-CoV and SARS-CoV-2 share many features, including that the spike proteins, which bind mACE2, have almost identical 3-D structure in the receptor-binding domain [1]. Animal and in vitro studies on SARS-CoV point to the importance of mACE2, and ADAM-17-mediated mACE2 shedding, for the development of severe ALI [1, 2]. For example, overexpression of human ACE2 increases disease severity in SARS-CoV-infected mice [1]. Also, ADAM-17 silencing decreases host cell entry of SARS-CoV [2]. The spike protein of the coronavirus HNL63CoV, which results only in common cold, does not induce mACE2 shedding [2]. High mACE2 and/or high ADAM-17 activity may therefore be risk factors for severe COVID-19 [1, 2]. Since high sACE2 could indicate high mACE2 and/or high ADAM-17 activity, sACE2 may be a marker of both susceptibility and severity of COVID-19.

The longitudinal study design is a strength of the present study. Study limitations include only following the subject into young adulthood, description of normal biology only, and the inability to, in serum, analyze mACE2 and cell ADAM-17 activity. However, the cleavage and the release of mACE2 due to ADAM-17 activity have already been well characterized [2, 3].

In conclusion, this study shows that subjects with higher risk for severe COVID-19 [4] had higher sACE2 (adults>children and men>women). We suggest that further studies evaluate if high sACE2 is a risk factor for severe COVID-19 and to what extent sACE2 is related to increased ADAM-17 activity and mACE2 shedding.

Availability of data and materials

All data generated or analyzed during this study are included in this published article. The corresponding author (PS) can be contacted for more information.



Membrane-bound angiotensin-converting enzyme 2


Soluble angiotensin-converting enzyme 2


Coronavirus disease 2019


Severe acute respiratory syndrome coronavirus


A disintegrin and metalloproteinase-17


Acute lung injury



POP study:

Pediatric osteoporosis prevention study


Normalized Protein eXpression


  1. 1.

    Zhang H, Penninger JM, Li Y, Zhong N, Slutsky AS. Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target. Intensive Care Med. 2020;46(4):586–90.

    CAS  Article  Google Scholar 

  2. 2.

    Haga S, Yamamoto N, Nakai-Murakami C, et al. Modulation of TNF-alpha-converting enzyme by the spike protein of SARS-CoV and ACE2 induces TNF-alpha production and facilitates viral entry. Proc Natl Acad Sci U S A. 2008;105(22):7809–14.

    CAS  Article  Google Scholar 

  3. 3.

    Patel VB, Clarke N, Wang Z, et al. Angiotensin II induced proteolytic cleavage of myocardial ACE2 is mediated by TACE/ADAM-17: a positive feedback mechanism in the RAS. J Mol Cell Cardiol. 2014;66:167–76.

    CAS  Article  Google Scholar 

  4. 4.

    Grasselli G, Zangrillo A, Zanella A, et al. Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy. JAMA. 2020;323(16):1574-81.

  5. 5.

    AlGhatrif M, Cingolani O, Lakatta EG. The Dilemma of Coronavirus Disease 2019, Aging, and Cardiovascular Disease: Insights From Cardiovascular Aging Science. JAMA Cardiol. 2020.

  6. 6.

    Cronholm F, Lindgren E, Rosengren BE, Dencker M, Karlsson C, Karlsson MK. Daily school physical activity from before to after puberty improves bone mass and a musculoskeletal composite risk score for fracture. Sports. 2020;8:40.

Download references


Not applicable


The research was funded by the Swedish Research Council for Sport Science, the Herman Järnhardt Foundation, Skåne Regional Foundations, and ALF Foundations. None of the funders had any influence on study design, data collection, interpretation, or writing of the manuscript.

Author information




The present study on the POP cohort for which MK is the principal investigator was designed by PS and MK. Data were analyzed by all authors. PS wrote the first draft of the manuscript. All authors critically assessed the manuscript and approved the final manuscript.

Corresponding author

Correspondence to Per Swärd.

Ethics declarations

Ethics approval and consent to participate

Ethical approval has been obtained for POP study at the Regional Ethics Committee at the Lund University, Lund, Sweden (LU 2015/118). Parent provided written informed consent was obtained for all children included in the study. In all adults, new written informed consent was provided.

Consent for publication

Not applicable

Competing interests

None of the authors has any disclosures or competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Swärd, P., Edsfeldt, A., Reepalu, A. et al. Age and sex differences in soluble ACE2 may give insights for COVID-19. Crit Care 24, 221 (2020).

Download citation